Frazier Life Sciences logo

Frazier Life Sciences

frazierls.com

Frazier Life Sciences is an investment firm that partners with and builds companies developing novel therapeutics, supporting them from early stages through public markets. It invests in private and public biopharmaceutical companies to advance innovative treatments across major therapeutic areas. Its mission is to support the development and commercialization of transformational therapeutics.

Facts

Sectors
Venture Capital and Private Equity Principals
Employees
11–50

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Frazier Life Sciences

Weekly Tech Pulse: CRV closes $750M flagship fund as Frazier Life Sciences raises $1.3B; 4AG Robotics $40M, Strand Therapeutics $153M

This roundup reports venture funding moves: CRV closed a smaller $750M flagship fund after returning capital and shifting to a leaner strategy; Frazier Life Sciences raised a record $1.3B for biotech investments; other startups including 4AG Robotics and Strand Therapeutics secured $40M and $153M respectively.

People

  • Gordon Empey
    Gordon Empey Executive, Partner, COO and General Counsel
  • Jennifer Martin Executive, Chief Financial Officer and Partner

Online

Questions about Frazier Life Sciences

What is Frazier Life Sciences?

frazierls.com

Who are the people behind Frazier Life Sciences?

Seattle Flow lists Gordon Empey (Executive, Partner, COO and General Counsel) and Jennifer Martin (Executive, Chief Financial Officer and Partner) at Frazier Life Sciences.

How many people work at Frazier Life Sciences?

Frazier Life Sciences has 11–50 employees.